{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:49:52Z","timestamp":1792590592203,"version":"4.5.0"},"reference-count":29,"publisher":"MyJove Corporation","issue":"232","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/71364","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:00:25Z","timestamp":1781650825000},"source":"Crossref","is-referenced-by-count":0,"title":["Unveiling acute toxicity trends in nasopharyngeal carcinoma: A global bibliometric perspective"],"prefix":"10.3791","author":[{"given":"Huiling","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianghui","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiguo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyan","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","type":"journal-article","article-title":"Nasopharyngeal carcinoma","volume":"394","author":"Chen","year":"2019","unstructured":"Chen YP et al. Nasopharyngeal carcinoma. Lancet. 2019;394:64\u201380.","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.radonc.2021.07.024","type":"journal-article","article-title":"A randomized, controlled phase II trial of maxillofacial and oral massage in attenuating severe radiotherapy-induced oral mucositis and lipid metabolite changes in nasopharyngeal carcinoma","volume":"163","author":"Yang","year":"2021","unstructured":"Yang G et al. A randomized, controlled phase II trial of maxillofacial and oral massage in attenuating severe radiotherapy-induced oral mucositis and lipid metabolite changes in nasopharyngeal carcinoma. Radiother Oncol. 2021;163:76\u201382.","journal-title":"Radiother Oncol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"6743","DOI":"10.1038\/s41598-021-97814-2","type":"journal-article","article-title":"Radiation-induced acute injury of intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy in induction chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a prospective cohort study","volume":"11","author":"Yao","year":"2021","unstructured":"Yao Z et al. Radiation-induced acute injury of intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy in induction chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a prospective cohort study. Sci Rep. 2021;11:6743.","journal-title":"Sci Rep"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3389\/fonc.2020.00930","type":"journal-article","article-title":"Quality of life, toxicity and unmet needs in nasopharyngeal cancer survivors","volume":"10","author":"McDowell","year":"2020","unstructured":"McDowell L et al. Quality of life, toxicity and unmet needs in nasopharyngeal cancer survivors. Front Oncol. 2020;10:930.","journal-title":"Front Oncol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1177\/0300060519858031","type":"journal-article","article-title":"Toxicities of chemoradiotherapy and radiotherapy in nasopharyngeal carcinoma: an updated meta-analysis","volume":"47","author":"Wang","year":"2019","unstructured":"Wang C et al. Toxicities of chemoradiotherapy and radiotherapy in nasopharyngeal carcinoma: an updated meta-analysis. J Int Med Res. 2019;47:2832\u20132847.","journal-title":"J Int Med Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/cac2.12218","type":"journal-article","article-title":"The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma","volume":"41","author":"Tang","year":"2021","unstructured":"Tang LL et al. The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma. Cancer Commun. 2021;41:1195\u20131227.","journal-title":"Cancer Commun"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1470-2045(10)70290-4","type":"journal-article","article-title":"Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial","volume":"12","author":"Nutting","year":"2011","unstructured":"Nutting CM et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol. 2011;12:127\u2013136.","journal-title":"Lancet Oncol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0360-3016(02)02724-4","type":"journal-article","article-title":"Intensity-modulated radiation therapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience","volume":"53","author":"Lee","year":"2002","unstructured":"Lee N et al. Intensity-modulated radiation therapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys. 2002;53:12\u201322.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S1470-2045(16)30410-7","type":"journal-article","article-title":"Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial","volume":"17","author":"Sun","year":"2016","unstructured":"Sun Y et al. Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial. Lancet Oncol. 2016;17:1509\u20131520.","journal-title":"Lancet Oncol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1200\/JCO.2008.19.9109","type":"journal-article","article-title":"Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: Radiation Therapy Oncology Group phase II trial 0225","volume":"27","author":"Lee","year":"2009","unstructured":"Lee N et al. Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: Radiation Therapy Oncology Group phase II trial 0225. J Clin Oncol. 2009;27:3684\u20133690.","journal-title":"J Clin Oncol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.radonc.2012.08.013","type":"journal-article","article-title":"A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma","volume":"104","author":"Peng","year":"2012","unstructured":"Peng G et al. A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. Radiother Oncol. 2012;104:286\u2013293.","journal-title":"Radiother Oncol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.radonc.2013.10.020","type":"journal-article","article-title":"Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities","volume":"110","author":"Sun","year":"2014","unstructured":"Sun X et al. Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities. Radiother Oncol. 2014;110:398\u2013403.","journal-title":"Radiother Oncol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.ijrobp.2004.05.022","type":"journal-article","article-title":"Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience","volume":"60","author":"Kam","year":"2004","unstructured":"Kam MKM et al. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys. 2004;60:1440\u20131450.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1200\/JCO.2008.18.1545","type":"journal-article","article-title":"Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma","volume":"27","author":"Hui","year":"2009","unstructured":"Hui EP et al. Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma. J Clin Oncol. 2009;27:242\u2013249.","journal-title":"J Clin Oncol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"6966","DOI":"10.1200\/JCO.2004.00.7542","type":"journal-article","article-title":"Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group","volume":"23","author":"Lee","year":"2005","unstructured":"Lee AWM et al. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group. J Clin Oncol. 2005;23:6966\u20136975.","journal-title":"J Clin Oncol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/jnci\/djq258","type":"journal-article","article-title":"Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy versus radiotherapy alone for regionally advanced nasopharyngeal carcinoma","volume":"102","author":"Lee","year":"2010","unstructured":"Lee AWM et al. Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy versus radiotherapy alone for regionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst. 2010;102:1188\u20131198.","journal-title":"J Natl Cancer Inst"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"106785","DOI":"10.1016\/j.micpath.2024.106785","type":"journal-article","article-title":"Efficacy of probiotics in the treatment of oral mucositis in head and neck cancer patients: a systematic review and meta-analysis","volume":"193","author":"Lin","year":"2024","unstructured":"Lin P et al. Efficacy of probiotics in the treatment of oral mucositis in head and neck cancer patients: a systematic review and meta-analysis. Microb Pathog. 2024;193:106785.","journal-title":"Microb Pathog"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"63026","DOI":"10.18632\/oncotarget.18450","type":"journal-article","article-title":"Predictive single nucleotide polymorphism markers for acute oral mucositis in patients with nasopharyngeal carcinoma treated with radiotherapy","volume":"8","author":"Le","year":"2017","unstructured":"Le Z et al. Predictive single nucleotide polymorphism markers for acute oral mucositis in patients with nasopharyngeal carcinoma treated with radiotherapy. Oncotarget. 2017;8:63026\u201363037.","journal-title":"Oncotarget"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3892\/ol.2023.14130","type":"journal-article","article-title":"Lack of association between XRCC1 SNPs and acute radiation-induced injury or prognosis in patients with nasopharyngeal carcinoma","volume":"26","author":"Zheng","year":"2023","unstructured":"Zheng Y et al. Lack of association between XRCC1 SNPs and acute radiation-induced injury or prognosis in patients with nasopharyngeal carcinoma. Oncol Lett. 2023;26:544.","journal-title":"Oncol Lett"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"110846","DOI":"10.1016\/j.radonc.2025.110846","type":"journal-article","article-title":"Delphi consensus-based recommendations of tools and outcomes for the assessment of radiation dermatitis severity","volume":"206","author":"Rahman","year":"2025","unstructured":"Rahman SM et al. Delphi consensus-based recommendations of tools and outcomes for the assessment of radiation dermatitis severity. Radiother Oncol. 2025;206:110846.","journal-title":"Radiother Oncol"},{"key":"ref21","first-page":"6061","type":"journal-article","article-title":"Concordance of the WHO, RTOG, and CTCAE v4.0 grading scales for the evaluation of oral mucositis associated with chemoradiation therapy for the treatment of oral and oropharyngeal cancers","volume":"29","author":"Villa","year":"2021","unstructured":"Villa A et al. Concordance of the WHO, RTOG, and CTCAE v4.0 grading scales for the evaluation of oral mucositis associated with chemoradiation therapy for the treatment of oral and oropharyngeal cancers. Support Care Cancer. 2021;29:6061\u20136068.","journal-title":"Support Care Cancer"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4103\/jcrt.jcrt_169_21","type":"journal-article","article-title":"Clinical outcome of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy in locally advanced nasopharyngeal carcinoma: comparative study at SKIMS Tertiary Care Institute","volume":"18","author":"Fatima","year":"2022","unstructured":"Fatima K et al. Clinical outcome of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy in locally advanced nasopharyngeal carcinoma: comparative study at SKIMS Tertiary Care Institute. J Cancer Res Ther. 2022;18:133\u2013139.","journal-title":"J Cancer Res Ther"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.ijrobp.2024.11.096","type":"journal-article","article-title":"Artificial intelligence-empowered multistep integrated radiation therapy workflow for nasopharyngeal carcinoma","volume":"122","author":"Yang","year":"2025","unstructured":"Yang YX et al. Artificial intelligence-empowered multistep integrated radiation therapy workflow for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2025;122:902\u2013913.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s12672-025-02458-7","type":"journal-article","article-title":"Risk factors and prediction models for severe radiation-induced oral mucositis in patients with nasopharyngeal carcinoma undergoing chemoradiotherapy","volume":"16","author":"Liang","year":"2025","unstructured":"Liang Y et al. Risk factors and prediction models for severe radiation-induced oral mucositis in patients with nasopharyngeal carcinoma undergoing chemoradiotherapy. Discov Oncol. 2025;16:903.","journal-title":"Discov Oncol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11547-024-01901-z","type":"journal-article","article-title":"A multi-center, multi-organ, multi-omic prediction model for treatment-induced severe oral mucositis in nasopharyngeal carcinoma","volume":"130","author":"Nicol","year":"2025","unstructured":"Nicol AJ et al. A multi-center, multi-organ, multi-omic prediction model for treatment-induced severe oral mucositis in nasopharyngeal carcinoma. Radiol Med. 2025;130:161\u2013178.","journal-title":"Radiol Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12943-022-01631-8","type":"journal-article","article-title":"A two-stage genome-wide association study to identify novel genetic loci associated with acute radiotherapy toxicity in nasopharyngeal carcinoma","volume":"21","author":"Wang","year":"2022","unstructured":"Wang Y et al. A two-stage genome-wide association study to identify novel genetic loci associated with acute radiotherapy toxicity in nasopharyngeal carcinoma. Mol Cancer. 2022;21:169.","journal-title":"Mol Cancer"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/1754-9485.13546","type":"journal-article","article-title":"Delta-radiomics-based models for toxicity prediction in radiotherapy: a systematic review and meta-analysis","volume":"67","author":"Tan","year":"2023","unstructured":"Tan D et al. Delta-radiomics-based models for toxicity prediction in radiotherapy: a systematic review and meta-analysis. J Med Imaging Radiat Oncol. 2023;67:564\u2013579.","journal-title":"J Med Imaging Radiat Oncol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"110648","DOI":"10.1016\/j.radonc.2024.110648","type":"journal-article","article-title":"Intensity-modulated proton therapy versus volumetric-modulated arc therapy in patients with nasopharyngeal carcinoma: a long-term, multicenter cohort study","volume":"202","author":"Wu","year":"2025","unstructured":"Wu CN et al. Intensity-modulated proton therapy versus volumetric-modulated arc therapy in patients with nasopharyngeal carcinoma: a long-term, multicenter cohort study. Radiother Oncol. 2025;202:110648.","journal-title":"Radiother Oncol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e27747","DOI":"10.1002\/pbc.27747","type":"journal-article","article-title":"Unintended consequences of evolution of the Common Terminology Criteria for Adverse Events","volume":"66","author":"Miller","year":"2019","unstructured":"Miller TP et al. Unintended consequences of evolution of the Common Terminology Criteria for Adverse Events. Pediatr Blood Cancer. 2019;66:e27747.","journal-title":"Pediatr Blood Cancer"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jove.com\/t\/71364\/unveiling-acute-toxicity-trends-nasopharyngeal-carcinoma-global","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:30:05Z","timestamp":1792589405000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/71364\/unveiling-acute-toxicity-trends-nasopharyngeal-carcinoma-global"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":29,"journal-issue":{"issue":"232","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3791\/71364","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]}}}